Bausch Health Companies: Top 25 Undervalued Toronto Stock Exchange Stocks (BHC)
Bausch Health Companies is now ranked among the top 25 undervalued stocks listed on the Toronto Stock Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
- Small, micro and nano group market capitalization (<10B)
Stocks in this category are held primarily for capital appreciation and/or dividends.
The Toronto Stock Exchange (TSX) is the largest exchange in Canada and one of the largest in the world. It is home for “senior” well-established equities.
Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
---|---|---|---|---|---|---|---|---|
TIXT | TELUS Intl | 12.04 | 24.15 | 12.11 (100.6%) | 136573 | 3323.0 | 0.0 | 47.2 |
LSPD | Lightspeed Commerce | 24.80 | 42.41 | 17.61 (71.0%) | 483903 | 3806.3 | 0.0 | 0.0 |
BTO | B2Gold | 3.79 | 6.18 | 2.39 (62.9%) | 3060947 | 4916.3 | 5.8 | 11.0 |
BNRE | Brookfield Reinsurance | 52.74 | 82.73 | 29.99 (56.9%) | 6535 | 3780.7 | 0.7 | 7.7 |
FM | First Quantum Minerals | 12.61 | 19.46 | 6.85 (54.4%) | 2498769 | 8750.3 | 1.7 | 10.5 |
NTR | Nutrien | 69.59 | 104.88 | 35.29 (50.7%) | 1504575 | 34450.9 | 4.1 | 11.6 |
NVEI | Nuvei | 33.11 | 48.37 | 15.26 (46.1%) | 279185 | 4606.9 | 0.8 | 0.0 |
BEPC | Brookfield Renewable | 37.66 | 54.65 | 16.99 (45.1%) | 171845 | 6765.7 | 4.9 | 3.1 |
AQN | Algonquin Power | 8.12 | 11.47 | 3.35 (41.3%) | 2123777 | 5590.0 | 7.2 | 0.0 |
CLS | Celestica | 48.35 | 66.46 | 18.11 (37.5%) | 457274 | 5816.5 | 0.0 | 17.8 |
BHC | Bausch Health Companies | 10.70 | 14.46 | 3.76 (35.2%) | 287594 | 3909.8 | 0.0 | 0.0 |
AP-UN | Allied Properties REIT | 17.78 | 23.80 | 6.02 (33.9%) | 563768 | 2485.0 | 9.9 | 0.0 |
AC | Air Canada | 18.25 | 23.19 | 4.94 (27.1%) | 2015328 | 6862.0 | 0.0 | 3.1 |
PXT | Parex Resources | 21.99 | 27.82 | 5.83 (26.5%) | 444215 | 2323.9 | 6.8 | 3.1 |
TA | TransAlta | 9.76 | 12.11 | 2.35 (24.1%) | 725170 | 2566.9 | 2.3 | 4.5 |
PBH | Premium Brands Hldgs | 93.37 | 113.89 | 20.52 (22.0%) | 30652 | 4164.3 | 3.3 | 38.4 |
DOO | BRP | 85.71 | 104.30 | 18.59 (21.7%) | 223384 | 6669.7 | 0.8 | 7.3 |
RBA | RB Global | 86.93 | 104.86 | 17.93 (20.6%) | 139208 | 15960.5 | 1.7 | 63.1 |
SAP | Saputo | 28.57 | 34.42 | 5.85 (20.5%) | 425760 | 12086.9 | 2.6 | 18.8 |
ACO-X | Atco | 38.19 | 46.00 | 7.81 (20.4%) | 163662 | 4329.7 | 5.0 | 10.3 |
EIF | Exchange Income | 46.62 | 55.57 | 8.95 (19.2%) | 91056 | 2588.1 | 5.4 | 17.8 |
ABX | Barrick Gold | 21.30 | 25.36 | 4.06 (19.1%) | 2838183 | 37381.5 | 2.6 | 514.8 |
DIR-UN | Dream Industrial REIT | 13.74 | 16.19 | 2.45 (17.9%) | 436228 | 3891.7 | 5.1 | 52.1 |
EMP-A | Empire Co | 34.60 | 40.71 | 6.11 (17.7%) | 342664 | 8645.3 | 2.1 | 11.5 |
CURA | Curaleaf Holdings | 7.44 | 8.71 | 1.27 (17.1%) | 476613 | 5396.4 | 0.0 | 0.0 |
All data provided as of February 04, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Bausch Health Companies
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Bausch Health Companies is listed under BHC on the Toronto Stock Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.